59 related articles for article (PubMed ID: 18551894)
1. Immune response against angiosarcoma following lower fluence rate clinical photodynamic therapy.
Thong PS; Olivo M; Kho KW; Bhuvaneswari R; Chin WW; Ong KW; Soo KC
J Environ Pathol Toxicol Oncol; 2008; 27(1):35-42. PubMed ID: 18551894
[TBL] [Abstract][Full Text] [Related]
2. Clinical PDT dose dosimetry for pleural Photofrin-mediated photodynamic therapy.
Sun H; Ong Y; Yang W; Sourvanos D; Dimofte A; Busch TM; Singhal S; Cengel KA; Zhu TC
J Biomed Opt; 2024 Jan; 29(1):018001. PubMed ID: 38223299
[TBL] [Abstract][Full Text] [Related]
3. Beyond the Barriers of Light Penetration: Strategies, Perspectives and Possibilities for Photodynamic Therapy.
Mallidi S; Anbil S; Bulin AL; Obaid G; Ichikawa M; Hasan T
Theranostics; 2016; 6(13):2458-2487. PubMed ID: 27877247
[TBL] [Abstract][Full Text] [Related]
4. Light Fluence Rate and Tissue Oxygenation (S
Dupre PJ; Ong YH; Friedberg J; Singhal S; Carter S; Simone CB; Finlay JC; Zhu TC; Cengel KA; Busch TM
Photochem Photobiol; 2020 Mar; 96(2):417-425. PubMed ID: 32048732
[TBL] [Abstract][Full Text] [Related]
5. Treatment planning for photodynamic therapy of abscess cavities using patient-specific optical properties measured prior to illumination.
Li Z; Hannan MN; Sharma AK; Baran TM
medRxiv; 2023 Nov; ():. PubMed ID: 37961683
[TBL] [Abstract][Full Text] [Related]
6. Determination of in vivo light fluence distribution in a heterogeneous prostate during photodynamic therapy.
Li J; Zhu TC
Phys Med Biol; 2008 Apr; 53(8):2103-14. PubMed ID: 18369279
[TBL] [Abstract][Full Text] [Related]
7. A novel investigational preclinical model to assess fluence rate for dental oral craniofacial tissues.
Sourvanos D; Zhu TC; Dimofte A; Busch TM; Lander B; Burrell JC; Neiva R; Fiorellini JP
Photodiagnosis Photodyn Ther; 2024 Apr; 46():104015. PubMed ID: 38373469
[TBL] [Abstract][Full Text] [Related]
8. In-Vivo Optical Monitoring of the Efficacy of Epidermal Growth Factor Receptor Targeted Photodynamic Therapy: The Effect of Fluence Rate.
Peng W; de Bruijn HS; Ten Hagen TLM; Berg K; Roodenburg JLN; van Dam GM; Witjes MJH; Robinson DJ
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31940973
[TBL] [Abstract][Full Text] [Related]
9. Tools of clinical Photodynamic Therapy (PDT): A Mini Compendium.
Allison RR; Huang Z; Dallimore I; Moghissi K
Photodiagnosis Photodyn Ther; 2024 Apr; 46():104058. PubMed ID: 38513811
[TBL] [Abstract][Full Text] [Related]
10. Optimization and regeneration kinetics of lymphatic-specific photodynamic therapy in the mouse dermis.
Kilarski WW; Muchowicz A; Wachowska M; Mężyk-Kopeć R; Golab J; Swartz MA; Nowak-Sliwinska P
Angiogenesis; 2014 Apr; 17(2):347-57. PubMed ID: 23892627
[TBL] [Abstract][Full Text] [Related]
11. TLD1433-Mediated Photodynamic Therapy with an Optical Surface Applicator in the Treatment of Lung Cancer Cells In Vitro.
Chamberlain S; Cole HD; Roque J; Bellnier D; McFarland SA; Shafirstein G
Pharmaceuticals (Basel); 2020 Jun; 13(7):. PubMed ID: 32605213
[TBL] [Abstract][Full Text] [Related]
12. Integrated light dosimetry system for prostate photodynamic therapy.
Li J; Zhu TC; Zhou X; Andreea D; Finlay JC
Proc SPIE Int Soc Opt Eng; 2008 Jan; 6845():. PubMed ID: 26113761
[TBL] [Abstract][Full Text] [Related]
13. Prostate PDT dosimetry.
Zhu TC; Finlay JC
Photodiagnosis Photodyn Ther; 2006 Dec; 3(4):234-46. PubMed ID: 25046988
[TBL] [Abstract][Full Text] [Related]
14. Preliminary clinical and pharmacologic investigation of photodynamic therapy with the silicon phthalocyanine photosensitizer pc 4 for primary or metastatic cutaneous cancers.
Kinsella TJ; Baron ED; Colussi VC; Cooper KD; Hoppel CL; Ingalls ST; Kenney ME; Li X; Oleinick NL; Stevens SR; Remick SC
Front Oncol; 2011; 1():14. PubMed ID: 22649754
[TBL] [Abstract][Full Text] [Related]
15. A real-time IR navigation system for pleural photodynamic therapy with a 3D surface acquisition system.
Sun H; Sourvanos D; Potasek M; Parilov G; Beesonk C; Zhu TC
Proc SPIE Int Soc Opt Eng; 2023; 12359():. PubMed ID: 37206987
[TBL] [Abstract][Full Text] [Related]
16. Correction to "Characteristics of an Impaired PDT Response".
Photochem Photobiol; 2023; 99(6):1504. PubMed ID: 37902229
[No Abstract] [Full Text] [Related]
17. The use of nanomaterials in advancing photodynamic therapy (PDT) for deep-seated tumors and synergy with radiotherapy.
Dinakaran D; Wilson BC
Front Bioeng Biotechnol; 2023; 11():1250804. PubMed ID: 37849983
[TBL] [Abstract][Full Text] [Related]
18. Trial watch: an update of clinical advances in photodynamic therapy and its immunoadjuvant properties for cancer treatment.
Penetra M; Arnaut LG; Gomes-da-Silva LC
Oncoimmunology; 2023; 12(1):2226535. PubMed ID: 37346450
[TBL] [Abstract][Full Text] [Related]
19. Intraligand Excited States Turn a Ruthenium Oligothiophene Complex into a Light-Triggered Ubertoxin with Anticancer Effects in Extreme Hypoxia.
Roque Iii JA; Cole HD; Barrett PC; Lifshits LM; Hodges RO; Kim S; Deep G; Francés-Monerris A; Alberto ME; Cameron CG; McFarland SA
J Am Chem Soc; 2022 May; 144(18):8317-8336. PubMed ID: 35482975
[TBL] [Abstract][Full Text] [Related]
20. Boosting Tumor-Specific Immunity Using PDT.
Maeding N; Verwanger T; Krammer B
Cancers (Basel); 2016 Oct; 8(10):. PubMed ID: 27782066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
